A new report from AARP Public Policy Institute found that the top 25 drugs prescribed under Medicare Part D have nearly ...
Novo Nordisk expects Ozempic, which has been on the market since 2017, will be on Medicare's list of drugs to negotiate prices concessions, Bloomberg reported. The company told USA TODAY that it would ...
Medicare recipients who take expensive prescriptions will get a break this year with a $2,000 cap on drug costs.
AARP’s new research finds price growth for top Part D prescription drugs has exceeded inflation, making a case for allowing ...
Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face ...
Findings show the impact of drug companies’ relentless price increases, underscoring the importance of the changes included ...
Seniors on Medicare Part D will never pay more than $2,000 out-of-pocket for prescription drugs annually, thanks to a ...
A key cost-saving provision of the Inflation Reduction Act (IRA) goes into effect in the new year, limiting annual ...
More than 70,000 seniors in Washington state will save hundreds or thousands of dollars each year thanks to the new annual cap on out-of-pocket prescription drug costs for folks on Medicare Part D, ...
Top Medicare Part D drugs without price negotiations have seen a 98% increase in list prices since their launch. Read more ...
Medicare enrollees will now pay a maximum of $2,000 on out-of-pocket prescription drug costs annually as part of another ...
Before I took office, people with Medicare who took expensive drugs could face a crushing burden, paying $10,000 a year or more in copays for the drugs they need to stay alive,” said a statement from ...